Oppenheimer Asset Management Inc. Abiomed Inc Transaction History

Oppenheimer Asset Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$130.51 - $196.01 $11,745 - $17,640	-90 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$159.31 - $223.54 $32,658 - $45,825	-205 Reduced 69.49%	90 $15,000
Q3 2019 Oct 31, 2019	BUY	$175.89 - $279.23 $351 - $558	2 Added 0.68%	295 $52,000
Q2 2019 Aug 09, 2019	BUY	$250.96 - $284.94 $4,015 - $4,559	16 Added 5.78%	293 $76,000
Q1 2019 Apr 24, 2019	SELL	$276.39 - $362.25 $11,055 - $14,490	-40 Reduced 12.62%	277 $80,000
Q4 2018 Jan 30, 2019	BUY	$281.08 - $444.25 $89,102 - $140,827	317 New	317 $103,000
Q4 2017 Feb 07, 2018	SELL	$168.78 - $199.74 $56,710 - $67,112	-336 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $48,851 - $56,649	336	336 $57,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.